Virginia G. Piper Cancer Center Clinical Trials Archives

TGen-Scottsdale Healthcare battle tumor growth

clinical research advantage - vaccines

The safety and preliminary efficacy of a new class of tumor fighting drugs were reported by Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer… Read More →

TGen, Scottsdale Healthcare study may help pancreatic cancer patients

clinical research advantage - vaccines
by in Business News | Healthcare

A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was led by physicians from Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials, a partnership… Read More →